Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil
暂无分享,去创建一个
T. Sterling | A. Kritski | B. Andrade | S. Cavalcante | B. Durovni | M. Turner | M. Arriaga | A. Gomes-Silva | M. Araújo-Pereira | V. Rolla | A. Benjamin | A. Moreira | R. Spener-Gomes | M. Figueiredo | M. Cordeiro-Santos | B. K. S. Carvalho | A. Andrade | J. Oliveira | M. Rocha | A. Souza | H. N. Ibiapina | A. G. Costa | Elisangela C Silva
[1] T. Sterling,et al. Novel stepwise approach to assess representativeness of a large multicenter observational cohort of tuberculosis patients: The example of RePORT Brazil , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[2] I. Sia,et al. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers , 2018, Journal of Clinical Microbiology.
[3] M. Behr,et al. Latent Mycobacterium tuberculosis Infection and Interferon-Gamma Release Assays. , 2016, Microbiology spectrum.
[4] Peter J Dodd,et al. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling , 2016, PLoS medicine.
[5] A. Benedetti,et al. Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review. , 2014, Annals of the American Thoracic Society.
[6] Nancy A. Dreyer,et al. Interfacing Registries With Electronic Health Records , 2014 .
[7] M. Pai,et al. Impact of Blood Volume, Tube Shaking, and Incubation Time on Reproducibility of QuantiFERON-TB Gold In-Tube Assay , 2013, Journal of Clinical Microbiology.
[8] G. Mazurek,et al. Within-Subject Interlaboratory Variability of QuantiFERON-TB Gold In-Tube Tests , 2012, PloS one.
[9] G. Mazurek,et al. Affect Of Blood Collection Time On QuantiFERON®-TB Gold In-Tube Test Variability , 2012, ATS 2012.
[10] R. Gaur,et al. Preanalytical Delay Reduces Sensitivity of QuantiFERON-TB Gold In-Tube Assay for Detection of Latent Tuberculosis Infection , 2011, Journal of Clinical Microbiology.
[11] A. Lalvani,et al. Interferon gamma release assays: principles and practice. , 2010, Enfermedades infecciosas y microbiologia clinica.
[12] M. D. I. Brasil. Manual de Recomendações para o Controle da Tuberculose no Brasil , 2010 .
[13] P. Hopewell,et al. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. , 2008, The Lancet. Infectious diseases.
[14] M. Pai,et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[15] L. Fabbri,et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. , 2005, American journal of respiratory and critical care medicine.
[16] R. Horsburgh,et al. Priorities for the treatment of latent tuberculosis infection in the United States. , 2004, The New England journal of medicine.
[17] Callum G. Fraser,et al. Biological Variation: From Principles to Practice , 2001 .
[18] P. Andersen,et al. Specific immune-based diagnosis of tuberculosis , 2000, The Lancet.